SCHEMBL4899755

SCHEMBL4899755

CC(C)Nc1cc(Cl)nc(N)n1.CC(C)Nc1cc(Cl)nc(N)n1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 5/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C19 P33261 1/20 0.50
MAPT P10636 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
POLB P06746 1/20 0.47
GAA P10253 1/20 0.47
KMT2A Q03164 3/20 0.47
POLA1 P09884 1/20 0.47
AURKA O14965 1/20 0.43
PDPK1 O15530 1/20 0.43
TGFBR1 P36897 1/20 0.43
AURKB Q96GD4 1/20 0.43
ALDH1A1 P00352 1/20 0.42
NUDT1 P36639 1/20 0.41
KDM4E B2RXH2 2/20 0.41
HSP90AB1 P08238 2/20 0.40
HSP90AA1 P07900 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL135984 1.00 HRH4 (0.50) HRH4CYP2D6CYP2C19MAPTSMN1; SMN2
SCHEMBL29394574 1.00 HRH4 (0.50) HRH4CYP2D6CYP2C19MAPTSMN1; SMN2
Isopropylamine SCHEMBL28920760 0.96 HRH4 (0.48) HRH4CYP2D6CYP2C19MAPTSMN1; SMN2
SCHEMBL11757729 0.82 HRH4 (0.49) HRH4CYP2D6CYP2C19MAPTSMN1; SMN2
SCHEMBL10212550 0.80 HRH4 (0.53) HRH4MAPTKMT2AAURKAPDPK1
SCHEMBL1748325 0.80 GAA (0.48) HRH4MAPTPOLBGAAKMT2A
SCHEMBL15757061 0.80 HRH4 (0.44) HRH4CYP2D6CYP2C19MAPTSMN1; SMN2
SCHEMBL15757365 0.80 HRH4 (0.44) HRH4CYP2D6CYP2C19MAPTSMN1; SMN2
SCHEMBL28043946 0.80 HRH4 (0.44) HRH4CYP2D6CYP2C19MAPTSMN1; SMN2
SCHEMBL9315949 0.80 NUDT1 (0.44) HRH4CYP2D6CYP2C19MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3906245-B1 MULTIFUNCTIONAL ORGANOSILICON COMPOUND AND RELATED METHODS, COMPOUNDS, AND COMPOSITIONS DOW SILICONES CORP (US) 2024-05-29 EP disclosed
EP-3645640-B1 SILICONE-POLYETHER COPOLYMER, METHOD OF PREPARING SAME, AND SEALANT COMPRISING SAME DOW SILICONES CORP (US) 2024-03-06 EP disclosed
US-11884821-B2 Composition, polymer composite article formed therewith, and method of preparing same DOW SILICONES CORPORATION (US) 2024-01-30 US disclosed
WO-2023215360-A1 SILICONE-POLYETHER COPOLYMER, SEALANTS COMPRISING SAME, AND RELATED METHODS DOW SILICONES CORPORATION (US) 2023-11-09 WO disclosed
US-11807775-B2 Silicone-organic copolymer, sealants comprising same, and related methods DOW SILICONES CORPORATION (US) 2023-11-07 US disclosed
US-11760841-B2 Silicone-polycarbonate copolymer, sealants comprising same, and related methods DOW SILICONES CORPORATION (US) 2023-09-19 US disclosed
EP-3898779-B1 SILICONE-POLYESTER COPOLYMER, SEALANTS COMPRISING SAME, AND RELATED METHODS DOW SILICONES CORP (US) 2023-02-08 EP disclosed
EP-3898781-B1 SILICONE-POLYCARBONATE COPOLYMER, SEALANTS COMPRISING SAME, AND RELATED METHODS DOW SILICONES CORP (US) 2023-01-04 EP disclosed
US-20220064383-A1 SILICONE-POLYACRYLATE COPOLYMER, SEALANTS COMPRISING SAME, AND RELATED METHODS DOW SILICONES CORPORATION 2022-03-03 US disclosed
US-20220064482-A1 SILICONE-ORGANIC COPOLYMER, SEALANTS COMPRISING SAME, AND RELATED METHODS DOW SILICONES CORPORATION 2022-03-03 US disclosed
US-20140183398-A1 Nickel Containing Hydrosilylation Catalysts and Compositions Containing the Catalysts DOW SILICONES CORPORATION 2014-07-03 US disclosed
US-20140171547-A1 Bismuth Containing Complex and Condensation Reaction Curable Compositions and Methods for the Preparation and Use of the Compositions DOW CORNING CORPORATION 2014-06-19 US disclosed
US-20140135517-A1 Hydrosilylation Reaction Curable Compositions And Methods For Their Preparation And Use DOW CORNING CORPORATION (US) 2014-05-15 US disclosed
US-20140100347-A1 Metal Containing Condensation Reaction Catalysts, Methods for Preparing the Catalysts, and Compositions Containing the Catalysts DOW SILICONES CORPORATION 2014-04-10 US disclosed
US-20140039089-A1 Compositions Containing Phosphonate Catalysts And Methods For The Preparation And Use Of The Compositions DOW CORNING CORPORATION (US) 2014-02-06 US disclosed
US-20140018467-A1 COMPOSITIONS CONTAINING SULFONIC ACID CATALYSTS AND METHODS FOR THE PREPARATION AND USE OF THE COMPOSITIONS DOW CORNING CORPORATION (US) 2014-01-16 US disclosed
WO-2013052585-A2 IRON(III) CONTAINING COMPLEX AND CONDENSATION REACTION CATALYSTS, METHODS FOR PREPARING THE CATALYSTS, AND COMPOSITIONS CONTAINING THE CATALYSTS DOW CORNING CORPORATION (US) 2013-04-11 WO disclosed
WO-2013052588-A1 IRON(II) CONTAINING COMPLEX AND CONDENSATION REACTION CATALYSTS, METHODS FOR PREPARING THE CATALYSTS, AND COMPOSITIONS CONTAINING THE CATALYSTS DOW CORNING CORPORATION (US) 2013-04-11 WO disclosed
WO-2013043783-A2 COBALT CONTAINING HYDROSILYLATION CATALYSTS AND COMPOSITIONS CONTAINING THE CATALYSTS DOW CORNING CORPORATION (US) 2013-03-28 WO disclosed
US-20080118734-A1 Coating Compositions DOW CORNING IRELAND LTD. (IE) 2008-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140135517-A1 Hydrosilylation Reaction Curable Compositions And Methods For Their Preparation And Use HIRA, HIRIP3, CROCC HRH4 54/4885CYP2D6 3558/4885CYP2C19 2180/4885
US-20140183398-A1 Nickel Containing Hydrosilylation Catalysts and Compositions Containing the Catalysts HIRA, ALG8, CAD HRH4 26/4885CYP2D6 4318/4885CYP2C19 2496/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.